SCIEX launches new data independent acquisition, ZT Scan DIA, at ASMS 2024

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 58 sec. here
  • 14 min. at publisher
  • 📊 Quality Score:
  • News: 68%
  • Publisher: 71%

Biomarker ニュース

Catalyst,Efficacy,Life Science

At ASMS 2024, SCIEX, a global leader in life science analytical technologies, introduces ZT Scan DIA for LC-MS/MS, the next generation in data-independent acquisition (DIA) that leverages the combination of the quadrupole dimension with the rich MS2 data attainable from the Zeno trap.

From SCIEXJun 4 2024 At ASMS 2024, SCIEX, a global leader in life science analytical technologies, introduces ZT Scan DIA for LC-MS/MS, the next generation in data-independent acquisition that leverages the combination of the quadrupole dimension with the rich MS2 data attainable from the Zeno trap.

DIA allows for the measurement of all compounds within a sample in a targeted manner. It has been a central catalyst for shifting mass spectrometry from a discovery science to one that facilitates longitudinal studies, as required in clinical research and precision medicine research. However, the challenge remained to improve throughput and depth of coverage in proteomic measurements while maintaining consistency and quantitative precision.

ZT Scan DIA follows SWATH DIA and most recently, Zeno SWATH DIA, delivering the depth of coverage characteristic of DIA approaches but with the precision, sensitivity and selectivity of targeted quantitative workflows. To further optimize the potential of proteomic depth enabled by ZT Scan DIA, SCIEX announces a collaboration with Bioinformatics Solutions Inc. , provider of next-generation, deep learning proteomics solutions, AI-driven biotechnology solutions. Its PEAKS software suite is industry acknowledged as a leader in proteomic data processing.

With PEAKS software, we can exploit a new dimension of the spectral data to improve ID rates and quantitative accuracy.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 19. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し